Inovio Pharmaceuticals, Inc. (INO)
1.56
+0.02
(+1.30%)
USD |
NASDAQ |
Mar 26, 10:40
Inovio Pharmaceuticals Free Cash Flow : -88.92M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vaxart, Inc. | 7.569M |
| Stereotaxis, Inc. | -13.78M |
| Capricor Therapeutics, Inc. | -81.54M |
| Allogene Therapeutics, Inc. | -149.63M |
| Silvergate Capital Corp. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.37M |
| Cash from Investing (Quarterly) | -0.0582M |
| Cash from Financing (Quarterly) | 27.13M |
| Free Cash Flow Per Share (Quarterly) | -0.2826 |
| Free Cash Flow to Equity (Quarterly) | -18.85M |
| Free Cash Flow to Firm (Quarterly) | -19.50M |
| Free Cash Flow Yield | -114.8% |